天津滨海高新区：聚焦创新驱动 打造产业高地

Core Viewpoint - Tianjin Binhai High-tech Zone is focusing on the high-quality development of the biopharmaceutical industry during the 14th Five-Year Plan period, aiming for an annual output growth rate of 16% and maintaining a leading position in national rankings for three consecutive years [3][4]. Group 1: Development Overview - During the 14th Five-Year Plan, the biopharmaceutical industry is identified as a core leading industry, integrating technological and industrial innovation [3]. - The region has established nearly 20 national-level innovation platforms and over 60 municipal-level platforms in the biopharmaceutical field, receiving nearly 30 national and Tianjin municipal science awards [4]. Group 2: Infrastructure and Innovation - The establishment of a matrix of innovation platforms, including national key laboratories and the Haihe Laboratory, has been a focus, with multiple functional platforms such as GMP centers and incubators [4]. - The region has gathered over 100 companies in the cell and gene therapy industry chain, covering the entire industry chain from cell extraction to clinical application [4]. Group 3: Future Outlook - Looking ahead to the 15th Five-Year Plan, the goal is to establish a nationally leading biotechnological and biomanufacturing industry hub, focusing on five core industries: innovative drugs, medical devices, cell therapy, brain-computer interaction, and pharmaceutical services [5]. - The region aims to create a significant industrial cluster with national influence and global competitiveness in the biopharmaceutical sector [5][6].